Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FIVE-YEAR POSTOPERATIVE OUTCOMES IN PATIENTS WITH OPEN-ANGLE GLAUCOMA WHO UNDERWENT BIO-INTERVENTIONAL UVEOSCLERAL OUTFLOW ENHANCEMENT SURGERY: LONG-TERM OBSERVATIONAL FOLLOW-UP FROM THE CREST STUDY (THE CREST-XT STUDY)

NCT07480343 is registered in ClinicalTrials.gov with Iantrek, Inc. as lead sponsor.

NCT NCT07480343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07480343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FIVE-YEAR POSTOPERATIVE OUTCOMES IN PATIENTS WITH OPEN-ANGLE GLAUCOMA WHO UNDERWENT BIO-INTERVENTIONAL UVEOSCLERAL OUTFLOW ENHANCEMENT SURGERY: LONG-TERM OBSERVATIONAL FOLLOW-UP FROM THE CREST STUDY (THE CREST-XT STUDY)
Lead sponsor
Iantrek, Inc.
Phase
Observational
Overall status
Enrolling by invitation
Start date
September 15, 2025
Completion date
December 31, 2030
Enrollment
250 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

open-angle glaucoma (oag)